Journal of Viral Hepatitis

Implication of normal liver enzymes in liver disease
pp. 529-536(8)
Authors: Calvaruso, Vincenza; Craxì, Antonio

The correlation of hepatocyte nuclear factor 4 alpha and 3 beta with hepatitis B virus replication in the liver of chronic hepatitis B patients
pp. 537-546(10)
Authors: Long, Y.; Chen, E.; Liu, C.; Huang, F.; Zhou, T.; He, F.; Liu, L.; Liu, F.; Tang, H.

Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles
pp. 547-556(10)
Authors: Pham, T. N. Q.; Mercer, S. E.; Michalak, T. I.

Treatment of hepatitis C infection for current or former substance abusers in a community setting
pp. 557-567(11)
Authors: John-Baptiste, A.; Varenbut, M.; Lingley, M.; Nedd-Roderique, T.; Teplin, D.; Tomlinson, G.; Daiter, J.; Krahn, M.

Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies
pp. 568-577(10)
Authors: van den Berg, C. H. S. B.; van de Laar, T. J. W.; Kok, A.; Zuure, F. R.; Coutinho, R. A.; Prins, M.

Pegylated interferon alpha-2b (Peg-IFN α-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN α-2b plus ribavirin
pp. 578-585(8)
Authors: Oze, T.; Hiramatsu, N.; Yakushijin, T.; Kurokawa, M.; Igura, T.; Mochizuki, K.; Imanaka, K.; Yamada, A.; Oshita, M.; Hagiwara, H.; Mita, E.; Ito, T.; Inui, Y.; Hijioka, T.; Tamura, S.; Yoshihara, H.; Hayashi, E.; Inoue, A.; Imai, Y.; Kato, M.; Yoshida, Y.; Tatsumi, T.; Ohkawa, K.; Kiso, S.; Kanto, T.; Kasahara, A.; Takehara, T.; Hayashi, N.

Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin
pp. 586-594(9)
Authors: Hiramatsu, N.; Oze, T.; Yakushijin, T.; Inoue, Y.; Igura, T.; Mochizuki, K.; Imanaka, K.; Kaneko, A.; Oshita, M.; Hagiwara, H.; Mita, E.; Nagase, T.; Ito, T.; Inui, Y.; Hijioka, T.; Katayama, K.; Tamura, S.; Yoshihara, H.; Imai, Y.; Kato, M.; Yoshida, Y.; Tatsumi, T.; Ohkawa, K.; Kiso, S.; Kanto, T.; Kasahara, A.; Takehara, T.; Hayashi, N.

Evidence for action of ribavirin through the hepatitis C virus RNA polymerase
pp. 595-604(10)
Authors: Cannon, N. A.; Donlin, M. J.; Mayes, L. M.; Lyra, A. C.; Di Bisceglie, A. M.; Tavis, J. E.